HOME >> BIOLOGY >> NEWS
Stem Cell Research 101

To: Reporters, editors, daybook and calendar editors
From: Dennis O'Shea / 443-287-9960/ dro@jhu.edu
Re: Stem Cell Research 101: The Science, Ethics and Politics of Stem Cell Research

What: A one-day primer sponsored by The Johns Hopkins University for policymakers, journalists and citizens interested in stem cell research. Topics include the latest developments in both laboratories and legislatures and the debate over ethical issues.

When: Tuesday, Nov. 15; 9 a.m.-2 p.m. EST.

Where: Hilton Washington, 1919 Connecticut Ave. NW, Washington, D.C. 20009 Lincoln East and Monroe Rooms

Who (see below for detailed program):

  • Researchers John Gearhart, Johns Hopkins; Howard Zucker, Columbia University
  • Research leaders Chi Dang, Johns Hopkins; William B. Neaves, president, Stowers Institute for Medical Research
  • Research funder Zach Hall, president, California Institute for Regenerative Medicine
  • Bioethicists Hilary Bok, Kathy Hudson and Ruth Faden, Johns Hopkins; Alfonso Gomez-Lobo, Georgetown University
  • Rep. Mike Castle, R-Del., co-sponsor of the Castle-DeGette Stem Cell Research Enhancement Act, intended to accelerate progress toward medical breakthroughs by opening more stem cell lines to federally funded research.

Why: Stem cell research has opened the door to major advances in human health. Ethical and political concerns, however, greatly complicate the research. Stem Cell Research 101 will bring interested laypersons up to speed on the latest in the science and the debates about the science. It will bring frontline researchers, research policymakers, ethicists and political leaders together to discuss the issues from their perspectives.

Logistics: The cost, including lunch, is $125. Call 1-800-548-5481. News media may cover the seminar without charge. Contact Dennis O'S
'"/>

Contact: Dennis O'Shea
dro@jhu.edu
443-287-9960
Johns Hopkins University
2-Nov-2005


Page: 1 2 3

Related biology news :

1. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
2. Research shows skeleton to be endocrine organ
3. Research aims to identify markers for menopausal women at risk for deadly blood clot
4. Research team enlightens the reasons for severe blindness
5. Research teams uncover risk genes for multiple sclerosis
6. Research shows NPD1 protects a key component of vision
7. Researchers find pathway that controls cell size and division
8. Researchers watch antibiotics, bacteria meet at atomic level
9. Researchers discover gene responsible for Restless Legs Syndrome
10. Research study describes the role part of the brain plays in memory
11. NY Stem Cell Foundations 2nd Annual Translational Stem Cell Research Conference

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Stem Cell Research

(Date:4/1/2015)... 2015   Medisafe ™, the leading global medication ... iOS and Android smartphones and tablets, ... the platform to allow patients to track and correlate ... time, patients will be able to visualize in real-time ... biometrics, such as glucose levels and blood pressure. ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... of the "Global Gesture Recognition Market in Automotive ... The analysts forecast the Global Gesture Recognition market in ... over the period 2013-2018. Gesture recognition is ... to different gestures of an individual. Gesture recognition technology ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... and Voice Biometrics - Global Strategic Business Report" report to ... Face and Voice Biometrics in US$ Thousands by the following Segments: ... for the US, Canada , Japan ... , Middle East & Africa ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
(Date:4/16/2015)... (PRWEB) April 16, 2015 Capillus, ... distribution and physician network in Europe and Asia. ... has appointed Fernando Bermúdez, former Business Development Director ... An industry veteran, Mr. Bermúdez’s professional achievements include ... in Spain, while also penetrating the Portuguese marketplace ...
(Date:4/16/2015)... OncoTAb, Inc., a ... spin-out company, announced today the appointment of physician ... Chief Operating Officer (COO). Cooper brings to OncoTAb ... clinical diagnostic and biotechnology platforms in the fields ... extensive career transcends the field of medical and ...
(Date:4/16/2015)... 2015 /CNW/ - Bioenterprise Corporation is pleased to announce that ... Charlottetown , PEI.  Bioenterprise has established a ... Council for the commercialization of agricultural technologies and innovations. ... PEI ADAPT.  They have been at the heart of ... explains Dave Smardon , President & CEO of ...
(Date:4/16/2015)... -- Avelas Biosciences, an in vivo cancer ... that it has initiated a Phase 1b study of ... primary, non-recurrent breast cancer undergoing surgery. In commencing the ... Steven Chen , M.D., as vice president of ... study will enroll up to 39 women with stage ...
Breaking Biology Technology:Capillus, LLC Extends Laser Hair Therapy Products to Europe and Asia 2OncoTAb Names Dr. David L. Cooper as COO 2Bioenterprise Corporation Expands into the Maritimes 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3
Cached News: